Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||The role of oral flora in the development of chemotherapy-induced oral mucositis|
|Citation:||Journal Of Oral Pathology and Medicine, 2015; 44(2):81-87|
|Publisher:||John Wiley & Sons|
|Andrea M. Stringer and Richard M. Logan|
|Abstract:||Chemotherapy-induced mucositis is considered to be a major oncological problem, caused by the cytotoxic effects of cancer chemotherapy. In the last 10 years, there have been significant advances in the understanding of mucositis pathobiology. At the basic level, it is now well-understood that it is not just an epithelial process, but rather a complex interaction between epithelial and connective tissue compartments. There is also potential interaction between the oral microenvironment and the development of mucositis. Changes occur in the resident oral flora (commensal) throughout cancer treatment, and it is conceivable that these organisms and changes that occur may have an influence on the development of mucosal toxicity associated with cancer treatment. The aim of this review was to examine the potential contributions of oral microflora in the pathobiology of mucositis and identify pathways and interactions that could be targeted for therapeutic management of mucositis.|
|Keywords:||microbiota; Mucositis; nuclear factor kappa B; oral cavity; reactive oxygen species|
|Rights:||© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd|
|Appears in Collections:||Medical Sciences publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.